Share Success: Letters From Readers
I: From Ann
Submit Form Tuesday, July 28, 2015 at 17:17:30
Hi, my name is Ann. I had breast cancer in 2009 and had a mastectomy. My cancer was hormone receptor positive so I take Femora to block my hormones. After 4 years on the femora, I had a bone density test that showed I had osteopenia.
I was informed by my doctor that the bone density test would be completed again in 1 year and if the results were lower I would not be able to continue on the femora because of its effects on your bones.
I searched the internet for help with bone density and up came EZorb. I printed off all the information and carried it to my next doctors visit to ask his approval to start EZorb.
I was on EZorb for 6 months when the doctor ordered another bone density test. The results showed me to be back in the normal range.
Because of EZorb I am being allowed to take the femora for 10 years instead of 5. I couldn't be happier with the results I had from EZorb.
II: From Jean
Submit Form Thursday, April 30, 2015 at 12:10:45
Hi, my name is Jean and I have suffered from osteoporosis and osteoarthritis pain for many years. I had avoided taking the prescription drugs for osteoporosis until this past fall when I decided to take Evista at my doctor's recommendation.
That was a huge mistake! My osteoarthritis pain got much worse! I was in terrible pain!
I went online to see what I could learn about osteoarthritis and your website came up. After reading about your products and the many testimonials I decided to try it.
After being on Ezorb for less than a week, my pain was almost gone! I couldn't
believe it! After being on it now for about a month, I am virtually pain free. I am so pleased that I have ordered Marvlix and will be trying it as soon as it arrives.
Thank you so much! I am a very happy and satisfied customer!
III: From VKlein
Submit Form Friday, April 24, 2015 at 11:07:56
Hi, my name is VKlein. I started using Calcium EZORB last September 2014 after I was diagnosed with Osteoporosis.
My doctor wanted me to see a rheumatologist but instead I researched through the net and found out this product.
I have been feeling better. I can see the spur on my foot has not progressed and now I am able to walk with lesser pain. A progress report will follow after I have a new dexascan.
For those who are still taking meds for osteoporosis, I would recommend to give this
product a try.
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 70,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public.
Research News: Arrhythmias Pose Risk in Pulmonary Hypertension Patients
Supraventricular arrhythmias (SVAs) are common and usually cause clinical deterioration in patients with idiopathic pulmonary arterial hypertension (IPAH), a study shows.
Persistent SVAs were associated with an increased mortality risk, whereas successful treatment led to clinical recovery, the researchers report in the American Journal of Cardiology.
"These findings support that restoration and maintenance of sinus rhythm are important treatment goal[s] in IPAH patients", write Zhi-Cheng Jing (Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing) and co-authors.
The prospective, multi-center study involved 280 IPAH patients, aged an average of 39 years, of whom 40 had at least one SVA during an average 31 months of follow-up, giving a 6-year cumulative incidence of 15.8%.
Survival was significantly poorer in patients who developed SVAs than those who did not, with 1-year rates of 85% versus 92% and 6-year rates of 53% versus 75%. However, the survival disadvantage was confined to patients with persistent arrhythmia, which increased mortality risk nearly fivefold after accounting for potential confounders. By contrast, the survival of patients with transient SVAs was not significantly different to that of those without arrhythmias.
The most common SVAs were atrial fibrillation, flutter and tachycardia. Treatment successfully restored sinus rhythm in all cases of atrial tachycardia, but less than half of atrial flutter cases and only a quarter of atrial fibrillation cases.
Jing et al note that most patients with SVAs had marked clinical deterioration or worsening heart failure, with the most common signs being increasing dyspnoea on exertion, palpitations and fluid retention with leg oedema. However, one patient was asymptomatic at the time of diagnosis.
Also, the researchers found that markers of heart enlargement (increased right ventricular diameter and left atrial area) significantly increased the likelihood of patients developing an SVA, as did increased mean right atrial pressure and pulmonary vascular resistance.
"Thus, electrocardiogram (even Holter monitor), echocardiography and right heart catheterization should be part of our routine assessment for PAH patients", concludes the team.
Original research was published in Am J Cardiol 2015; Advance online publication.
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.